VOYA Investment Management
OREX

VOYA Investment Management’s Orexigen Therapeutics, Inc. OREX Stock Holding History

VOYA Investment Management’s Portfolio OREX Stock Details OREX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-4,193
Closed -$24K – 2658
2016
Q1 		$24K Hold
4,193
– – ﹤0.01% 2506
2015
Q4 		$72K Hold
4,193
– – ﹤0.01% 2518
2015
Q3 		$88K Sell
4,193
-1,998
-32% -$68.5K ﹤0.01% 2505
2015
Q2 		$306K Hold
6,191
– – ﹤0.01% 2252
2015
Q1 		$485K Hold
6,191
– – ﹤0.01% 1934
2014
Q4 		$375K Hold
6,191
– – ﹤0.01% 2126
2014
Q3 		$264K Hold
6,191
– – ﹤0.01% 2351
2014
Q2 		$383K Hold
6,191
– – ﹤0.01% 2183
2014
Q1 		$402K Hold
6,191
– – ﹤0.01% 2129
2013
Q4 		$349K Hold
6,191
– – ﹤0.01% 2220
2013
Q3 		$380K Hold
6,191
– – ﹤0.01% 2121
2013
Q2 		$362K Buy
+6,191
New +$381K ﹤0.01% 2103

Other funds holding OREX

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
TAM
Tiverton Asset Management Wilimington, Delaware $2.88B AUM 5.6% 1-Year Est. Return
SC
Samlyn Capital New York $5.86B AUM 36.3% 1-Year Est. Return
FCMI
Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
FCMI
Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

VOYA Investment Management's OREX Position: Q2 2016 in Review

VOYA Investment Management sold out of Orexigen Therapeutics, Inc. (OREX) in Q2 2016, closing a stake of 4,193 shares — an estimated $24K sold.

VOYA Investment Management first reported a position in OREX in Q2 2013 and held it in 12 quarters. The position peaked at $485K in Q1 2015. 73 funds tracked by Wall St. Rank hold OREX as of Q2 2016.

  • VOYA Investment Management reported no remaining Orexigen Therapeutics, Inc. position as of Q2 2016 after selling out during the quarter.
  • VOYA Investment Management sold 4,193 Orexigen Therapeutics, Inc. shares in Q2 2016, an estimated $24K.
  • VOYA Investment Management first reported a position in Orexigen Therapeutics, Inc. in Q2 2013 and held it in 12 quarters.
  • VOYA Investment Management's Orexigen Therapeutics, Inc. position peaked at $485K in Q1 2015.
  • 73 funds tracked by Wall St. Rank held Orexigen Therapeutics, Inc. as of Q2 2016.

Based on VOYA Investment Management's 13F filing for Q2 2016, filed 15 Aug 2016.